Towards Healthcare
Thermostable Vaccine Market
Updated Date: 28 January 2026   |   Report Code: 5117
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Thermostable Vaccine Market Size and Companies (2026-2035)

According to our projections, the thermostable vaccine sector is expected to grow from USD 9.27 billion in 2025 to USD 19.05 billion by 2035, reflecting a CAGR of 7.47%. The thermostable vaccine market is growing fast, driven by the need for heat-resistant vaccines that don’t require cold storage. These innovative vaccines improve access in remote areas, making immunization safer and more reliable worldwide.

Last Updated : 28 January 2026 Category: Biotechnology Insight Code: 5117 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Thermostable Vaccine Market Assessment

  • Overview
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Thermostable Vaccine Market Assessment

  • Overview
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Europe Thermostable Vaccine Market Assessment

  • Overview
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Asia Pacific Thermostable Vaccine Market Assessment

  • Overview
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Latin America Thermostable Vaccine Market Assessment

  • Overview
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Middle East and Africa Thermostable Vaccine Market Assessment

  • Overview
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Company Profiles

  • Serum Institute of India
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Sanofi
  • GSK
  • Hilleman Laboratories
  • Soligenix

Conclusion & Recommendations

FAQ's

Answer : The thermostable vaccine market is valued at USD 9.96 billion in 2026 and is projected to nearly double to USD 19.05 billion by 2035, growing at a steady 7.47% CAGR.

Answer : The biggest trend is moving beyond cold-chain dependency. Advances in freeze-dried formulations, heat-stable mRNA vaccines, and room-temperature storage are reshaping vaccine logistics.

Answer : Major players like Serum Institute of India, Sanofi, GSK, Hilleman Laboratories, and Soligenix are at the forefront.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar